Top Buy
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc | 21 | 0 | 2 | 0 | €101.65 | €184.14 | 81.151% |
| Syros Pharmaceuticals Inc. | 5 | 1 | 2 | 1 | €4.98 | €12.80 | 157.058% |
| Esperion Therapeutis.Inc. | 13 | 0 | 2 | 0 | €1.96 | €8.39 | 326.996% |
| Viracta Therapeutics Inc. | 2 | 0 | 2 | 0 | €0.81 | - | - |
| Johnson & Johnson | 32 | 1 | 2 | 0 | €137.52 | €196.74 | 43.060% |
| Twist Bioscience Corp | 5 | 0 | 2 | 0 | €37.03 | €40.00 | 8.021% |
| Personalis Inc | 6 | 0 | 2 | 0 | €1.50 | €3.24 | 116.640% |
| Agios Pharmaceuticals Inc. | 5 | 0 | 2 | 0 | €30.60 | €38.99 | 27.414% |
| Exelixis Inc. | 17 | 0 | 2 | 0 | €20.62 | €25.64 | 24.322% |
| Novo Nordisk A/S ADR | 17 | 1 | 2 | 0 | €113.50 | €130.00 | 14.537% |
| Adverum Biotechnologies Inc. | 6 | 1 | 2 | 0 | €1.38 | €4.66 | 237.768% |
| Fate Therapeutics Inc. | 5 | 2 | 2 | 1 | €3.93 | €8.27 | 110.175% |
| Insmed Inc. | 13 | 1 | 2 | 1 | €23.80 | €44.01 | 84.902% |
| Actinium Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €8.15 | €8.50 | 4.294% |
| Rhythm Pharmaceuticals | 14 | 0 | 2 | 0 | €38.20 | €46.08 | 20.635% |
| Viking Therapeutics Inc | 6 | 0 | 2 | 0 | €68.22 | €100.00 | 46.585% |
| Stoke Therapeutics Inc | 13 | 1 | 2 | 0 | €11.10 | €21.00 | 89.222% |
| MacroGenics Inc. | 11 | 0 | 3 | 0 | €14.20 | €20.00 | 40.845% |
| Zoetis Inc. A | 21 | 1 | 3 | 1 | €156.84 | €200.06 | 27.555% |
| Merck & Co. Inc. | 28 | 1 | 3 | 0 | €118.40 | €124.93 | 5.514% |
| X4 Pharmaceuticals, Inc. | 6 | 1 | 3 | 1 | €1.07 | €2.78 | 159.188% |
| AnaptysBio Inc | 8 | 1 | 3 | 0 | €24.80 | €46.24 | 86.452% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €371.40 | €421.61 | 13.518% |
| Krystal Biotech | 16 | 0 | 3 | 0 | €151.00 | €173.22 | 14.714% |
| Cytokinetics Inc. | 24 | 1 | 3 | 0 | €60.50 | €83.81 | 38.537% |